RESTASIS®

...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...

Medicine Products:

Benzoylecgonine Confirmation/Quantitation, Plasma Benzol, Whole Blood Bendiocarb, Serum or Plasma Bence Jones Protein, Quantitative Free Lambda Light Chains, Urine

(Date:12/2/2008)...tatives from the fitness,company Burn Machine ( w...rs,Hospitals for Children in Chicago last month t...cause; The Burn Machine donated more than $1500,w...the first ever Shriners,Wheelchair Bodybuilding C...-bin/prnh/20081203/CLW007 ) , "We knew the...

(Date:12/2/2008)...stantially higher rates of mental health problems ...from a systematic review and meta-analysis publish... studies over the past four decades containing dat...s people, Seena Fazel and colleagues of the Univer...84 homeless individuals based in the US, UK, mainl...

(Date:12/2/2008)...oups of immigrants in Oslo. Compared with Norwegia...s are seen for risk factors and actual diseases. T...stitute of Public Health. Five of the largest immi... ethnic Norwegian population. The report was commi... The five immigrant groups in this study come fro...

(Date:12/2/2008)...k, data review finds , , TUESDAY, Dec. 2... on the safety of the drug Trasylol (aprotinin), u...ry. , Trasylol is already the subject of contro...rom the market in 2007. , In the new study, Can... from 49 randomized clinical trials. They conclude...

Breaking Medicine News(10 mins):Health News:Burn Machine Speed Bag Knocks 'em Out at Shriners Wheelchair Bodybuilding Camp 2 Health News:Large health differences between population groups in Norway 2 Health News:Large health differences between population groups in Norway 3 Health News:Large health differences between population groups in Norway 4 Health News:Another Study Warns of Risk From Cardiac Surgery Drug 2

[0] Burn Machine Speed Bag Knocks 'em Out at Shriners Wheelchair Bodybuilding Camp [0] Higher rates of mental illness among the homeless in Western countries [0] Large health differences between population groups in Norway [0] Another Study Warns of Risk From Cardiac Surgery Drug

...ake is an effective way of identifying prostate ca...steoporosis, according to a research.// Researche..., Barcelona, Spain, looked at a cross-section of 3...nt were receiving androgen-deprivation therapy (AD...

...gain directed doctors in government-run medical ho...mes.// An official letter has been issued directi...pitals, primary health centres, community health c...ibe only the generic names of medicines and not th...

...idents of suicides and fratricides in the armed fo...or steps to "urgently" address the// issue. "The ...o be a cause of concern and must be addressed urge...ng the five-day Army Commanders' Conference here. ...

???'Of all the rights of women, the greatest is to be a mother.' ????………….. Lin Yutang been eulogized, since the// time of eve, as the symbol of abysmal and unconditional love. It is that exclusiv

Other Medicine News:Health News:Measuring Calcium Intake Help to Identify Osteoporosis in Prostate Cancer Patient 2 Health News:Antony Concerned Over Growing Suicide Rates in Armed Forces 2 Health News:Magic of Motherhood Through Egg Donation 2 Health News:Magic of Motherhood Through Egg Donation 3 Health News:Magic of Motherhood Through Egg Donation 4

Measuring Calcium Intake Help to Identify Osteoporosis in Prostate Cancer Patient Rajasthan Directs Doctors to Prescribe Medicines by Generic Names Antony Concerned Over Growing Suicide Rates in Armed Forces Magic of Motherhood Through Egg Donation

(Date:12/2/2008)...tCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biop...y antibodies for the treatment of cancer, inflamma... it has entered into an agreement expanding its Co...sbridge Capital Limited, a private investment grou...has committed to provide up to $75 million of capi...

(Date:12/1/2008)...eGen has announced that an oral,presentation of ...clinical,trial of TG101348 in myeloproliferative ...merican Society of Hematology (ASH) Meeting. , ..., Title: A Phase I Study of TG10... JAK2-Selective Inhibitor, in Patients with, ...

(Date:12/1/2008)... a two-way switch that, if turned off, causes lymp... they lose their identity and become more like blo...c. 1 Scientists at St.... that a certain differentiated cell type is so rea...stant expression of a gene called Prox1 to dissu...

(Date:12/1/2008)...ay, December 9 at 11:00 am ET to Discuss Phase 2 S...ISCO, Calif., Dec. 1 S...biopharmaceutical company focused on the developme...ics, today announced new data from its studies of ...presented during the 50th American Society of Hema...

Breaking Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2 Micromet Expands Committed Equity Financing Facility to $75 Million 3 Micromet Expands Committed Equity Financing Facility to $75 Million 4 Micromet Expands Committed Equity Financing Facility to $75 Million 5 Micromet Expands Committed Equity Financing Facility to $75 Million 6 Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2 Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3 Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2 Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3 Stern + Associates Signs New Clients to Health Care Practice 26591 1 Stern + Associates Signs New Clients to Health Care Practice 26591 2 Hurricane Devastation Touches the Nations Blood Supply 26589 1 Hurricane Devastation Touches the Nations Blood Supply 26589 2 AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 1 AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 2 AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 3 AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 4 alli 28TM 29 Partners with Breast Cancer Network of Strength 28TM 29 to Support Women Challenged by Breast Cancer Weight Loss or Both 7814 1 alli 28TM 29 Partners with Breast Cancer Network of Strength 28TM 29 to Support Women Challenged by Breast Cancer Weight Loss or Both 7814 2 alli 28TM 29 Partners with Breast Cancer Network of Strength 28TM 29 to Support Women Challenged by Breast Cancer Weight Loss or Both 7814 3

[0] Micromet Expands Committed Equity Financing Facility to $75 Million [0] TargeGen Affiliates Scheduled for Oral Presentation of Interim Clinical Trial Data at 2008 ASH Meeting in San Francisco for TG101348, a Potent, Selective, Oral JAK2 Inhibitor in Myeloproliferative Disease Patients [0] Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity [0] Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH

...NEVA, Switzerland, May 2, 2007 – Merck,Seron...I data on,safinamide, a new agent in Phase III dev...sease symptoms, were presented by Professor,Fabriz...th Annual,Meeting in Boston, Massachusetts, USA. T...d, double blind, placebo-controlled,international...

...ublished today in the Journal of the National Canc...and, 2 May 2007 - In a study published today in,th...novative cancer,drug MabThera was shown to improve...less of the chemotherapy regimen used.1 The,review...as seen for,the first time in patients with mantle...

Other Medicine Technology:Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 2 Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 3 Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 4 Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 5 MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 2 MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 3 MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 4

Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen

Products	RESTASIS®
Company	Allergan, Inc.
Item	RESTASIS®
Features
Description	RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% is the first and only therapy for patients with keratoconjunctivitis sicca (Dry Eye Disease) whose tear production is presumed to be supressed due to ocular inflammation.
Info	Allergan, Inc. Customer Service: (714) 246-4500